Medtronic plc (MDT) › Cost of RevenueMedtronic plc (MDT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2013: $4.13B2014: $4.33B2015: $6.31B2016: $9.14B2017: $9.29B2018: $9.07B2019: $9.15B2020: $9.42B2021: $10.48B2022: $10.14B2023: $10.72B2024: $11.22B2025: $11.63B$11.63B2013Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$11.63B+3.7%2024$11.22B+4.6%2023$10.72B+5.7%2022$10.14B-3.2%2021$10.48B+11.2%2020$9.42B+2.9%2019$9.15B+1.0%2018$9.07B-2.4%2017$9.29B+1.7%2016$9.14B+44.9%2015$6.31B+45.6%2014$4.33B+5.0%2013$4.13B—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share